Antiaggregation treatment – review of drugs, importance for clinical practice, and possibilities of determination of resistance to treatment

Česká verzia

Authors: P. Paulů; P. Toušek; P. Osmančík
Authors place of work: III. Interní-kardiologická klinika FN Královské Vinohrady a 3. lékařské fakulty UK, Přednosta: prof. MUDr. Petr Widimský, DrSc., FESC
Published in the journal: Prakt. Lék. 2011; 91(2): 73-76
Category: Reviews

Summary

Antiaggregation treatment is widely used in daily clinical practice. New antiaggregation drugs have been presented and other are under rapid development. Physicians are facing large discussions regarding resistance and responsiveness to antiaggregation treatment.

The goal of this review article is to describe pharmacological effect of previously used and new antiaggregant, present methods that can identify patients resistant to treatment and show possible impact of this testing in daily clinical practice.

Key words:
antiaggregation treatment, resistance, laboratory methods, ischemia.

Zdroje

1. Michelson, A.D. Platelets, 2nd edition. Canada: Elsevier 2007, 1343, ISBN 13: 978-0-12-369367-9.

2. Baigent, C., Collins, R., Appleby, P. et al. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. Br. Med. J. 1998; 316 (7141), p. 1337-1343.

3. Antiplatelet Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. Br. Med. J. 2002, 324, p. 71-86.

4. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348, p. 1329–1339.

5. Yusuf, S., Zhao, F., Mehta, S.R. et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. N. Engl. J. Med. 2001, p. 345: 494-502.

6. Mehta, S.R., Yusuf, S., Peters, R.J.G. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE Study. Lancet 2001, 358, p. 527-533.

7. Wiviott, S., Braunwald, E., McCabe, C.H. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2007, 357, p. 2001-2015.

8. Wallentin, L., Becker, R.C., Budaj, A. et al. Ticagrelor versus Clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2009, 11, p. 1045-1057.

9. Breet, N.J., van Werkum, J.W., Bouman, H.J. et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010, 303, p. 754-762.